Extended report
Demonstration of mast cell chemotactic activity in synovial fluid
from rheumatoid patients
N Olssona, A-K Ulfgrenb, G Nilssona
a Department of
Genetics and Pathology, Uppsala University, Uppsala, Sweden, b Department of Medicine,
Unit of Rheumatology, Karolinska Hospital, Stockholm, Sweden
Correspondence to: Dr G Nilsson, Department of Genetics and Pathology, Rudbeck Laboratory, Uppsala University, S-751 85 Uppsala, Sweden Gunnar.Nilsson{at}genpat.uu.se
Accepted for publication 25 July 2000
OBJECTIVES
The
significance of the mast cell in the pathogenesis of rheumatic diseases
has become more evident. Although mast cell hyperplasia is a feature of
rheumatoid arthritis, the nature of mast cell chemoattractants involved
in the recruitment of mast cells in joint diseases has not been studied
in any detail. In this study the presence of mast cell chemotactic
activity in synovial fluids was examined.
METHODS
Synovial
fluids from seven rheumatoid patients were tested in a modified Boyden
chamber, where a human mast cell line was used as responder. The
presence of stem cell factor (SCF) and transforming growth factor
(TGF
) was measured by enzyme linked immunosorbent assay (ELISA).
RESULTS
Six of the
seven synovial fluids tested exhibited mast cell chemotactic activity.
Two characterised human mast cell chemotaxins, SCF and TGF
, were
highly expressed in the synovium. Soluble SCF could be detected in all
fluids analysed. Blocking antibodies against SCF or TGF
almost
completely blocked the activity in one fluid, partially blocked the
activity in three, and did not affect the activity in two. Treatment of
the responder cells with pertussis toxin reduced the migratory response
against seven fluids, indicating the presence of chemoattractants
mediating their effect through Gi coupled receptors.
CONCLUSION
These data
demonstrate the presence of multiple factors in synovial fluid acting
as mast cell chemoattractants, two of which are SCF and TGF
that
contribute to the effect. These findings may be of importance for
developing new strategies to inhibit mast cell accumulation in
rheumatic diseases.
© 2001 by Annals of the Rheumatic Diseases
This article has been cited by other articles:
-
Gebhardt, T, Lorentz, A, Detmer, F, Trautwein, C, Bektas, H, Manns, M P, Bischoff, S C
(2005). Growth, phenotype, and function of human intestinal mast cells are tightly regulated by transforming growth factor {beta}1. Gut
54: 928-934
[Abstract] [Full Text] -
Cao, J., Papadopoulou, N., Kempuraj, D., Boucher, W. S., Sugimoto, K., Cetrulo, C. L., Theoharides, T. C.
(2005). Human Mast Cells Express Corticotropin-Releasing Hormone (CRH) Receptors and CRH Leads to Selective Secretion of Vascular Endothelial Growth Factor. J. Immunol.
174: 7665-7675
[Abstract] [Full Text] -
Tanimoto, K., Suzuki, A., Ohno, S., Honda, K., Tanaka, N., Doi, T., Yoneno, K., Ohno-Nakahara, M., Nakatani, Y., Ueki, M., Tanne, K.
(2004). Effects of TGF-{beta} on Hyaluronan Anabolism in Fibroblasts Derived from the Synovial Membrane of the Rabbit Temporomandibular Joint. JDR
83: 40-44
[Abstract] [Full Text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
